Objective The purpose of this study was to compare two different groups of drugs, aprotinin and dexamethasone for its efficacy in reducing post operative swelling and pain after third molar surgery. Methods Fifty consecutive patients requiring surgical removal of single mandibular third molar (class II position B) under local anesthesia were randomly divided into two groups, each group consisting of 25 patients. One group was administered 8 mg dexamethasone through intravenous route pre-operatively. The other group received 1 ml of Aprotinin through submucosal route in operating area after the onset of local anesthesia. Swelling was assessed by measuring facial contours at baseline and at 1st, 3rd and 7th post-operative days. Pain was measured on the 1st, 3rd and 7th post-operative days using visual analog scale. Based on statistical analysis (paired t test and Wilcoxon's signed ranking test), the results showed statistically significant difference in post operative swelling and pain on 3rd postoperative day in dexamethasone group as compared to aprotinin group. Results The results of present study showed a similar reduction in the severity of pain and swelling at the aprotinin and dexamethasone sites on 1st and 7th postoperative day. It was also noticed that the aprotinin promoted a greater reduction of swelling and pain on 3rd postoperative day. Conclusion It appeared that, benefits of aprotinin against the risks of dexamethasone and its efficacy in controlling pain and swelling after third molar surgery makes aprotinin to be a valuable alternative to dexamethasone.
Introduction
Inflammatory edema and pain is normal phenomena induced after any surgical procedure including surgical extraction of impacted lower third molar. Although, some amount of inflammation is necessary for proper wound healing, excess of inflammation leads to severe edema and pain which causes discomfort to the patient. It is by no means clear why some of these surgical extractions are followed by considerable discomfort, whilst others are affected to a much lesser degree [1] . The formation of postoperative edema, its complexities and control has been the subject of perpetual interest to oral surgeon, hence its control has become a subject of scientific enthusiasm.
Pain and edema of varying degree follow all operative procedures and many pharmacological and physical methods have been employed in an attempt to reduce them. In oral surgery, the principal effective physical method for relieving edema is the use of drains, whilst of all the pharmacological agents tried, the anti-inflammatory steroids appear to be the most successful and remain in common usage. Corticosteroids such as dexamethasone may inhibit the initial step in inflammatory process and have been extensively used in varying regimens and routes to lessen inflammatory process after third molar surgery [2] .
In 1957 Arth et al. synthesized a new family of steroid compounds containing in common a cyclopentonoperhydrophenanthrine ring with methyl group at the 16th carbon position of the nucleus. One of these compounds was dexamethasone. It exerts basic glucocorticoid action and is approximately 25 times more potent than hydrocortisone, 6 times than of prednisolone, 4 times that of methyl prednisolone and triamcinolone and equipotent to betamethasone [3, 4] .
Dexamethasone is a potent, highly selective, long acting, synthetic corticosteroid, which has potent antiinflammatory action [5] . Although the steroids appear to be the most successful for relieving edema after third molar removal, immunosuppressive effects of cortisol and its synthetic analogues are well recognized in medicine [6] . Previous studies on use of dexamethasone in third molar surgery have been concluded with an emphasis that there is a great need for well designed clinical research to further evaluate protocols for corticosteroid use [7] .
Aprotinin, a serine protease inhibitor was introduced in clinical use in 1950s. Its role was limited only in the treatment of pancreatitis wherein, it was extensively used for almost 40 years. Recently its ability to reduce bleeding and inflammation was discovered. The anti-inflammatory property was explained based on the inhibitory action of aprotinin on kallikrein and bradykinin which are potent inflammatory mediators. Of special interest has been the field of cardiovascular surgery where aprotinin has dramatically reduced surgical bleeding and also the inflammatory response to cardiac surgery [6] . Recently the antiinflammatory property of aprotinin has been utilized in lower third molar surgery by injecting it locally to control post-operative pain and edema [8] .
This prospective study was conducted to evaluate the ability of aprotinin to control pain and swelling following surgical extraction of lower third molars as compared to dexamethasone.
Materials and Method
Fifty consecutive patients who required surgical removal of single mandibular third molar under local anesthesia were selected for this randomized study. This study group consisted of 29 female and 21 male, age ranging from 20 to 40 years. Patients were categorized into two groups as aprotinin group and dexamethasone group. Selected patients were allocated to each group equally by randomization procedure, irrespective of age and sex.
For standardization of the sample we used following clinical and radiographic criteria:
Inclusion criteria:
(1) Healthy ambulatory patients (ASA class I) patients requiring removal of single impacted lower third molars which necessitates mucoperiosteal flap elevation, buccal bone guttering with or without sectioning of the tooth. Surgical and experimental procedures were explained verbally and in writing, and informed written consent was obtained from all patients before enrollment.
Pre-operative assessment A detailed general medical history of patient was recorded in each case as per proforma and was followed by clinical examination. Following measurements were made for all the selected patients.
Swelling
Facial swelling was evaluated by a modification of a method described by Schultze-Mosgau et al. [9] by a flexible tape. Measurements were taken by marking six fixed points and five surgical base lines [10] in order to cover all possible directions of extension of swelling. The measurements were made in closed mouth position (Fig. 1) . S1: from the lateral canthus of the eye to the angle of the mandible. S2: from ala of the nose to the angle of the mandible. S3: from the corner of the mouth to the angle of the mandible. S4: from the Menton to the angle of the mandible. S5: from the ala of the nose to the tragus of the ear.
Using the flexible scale to follow the contour of the face, linear distances were noted. The sum of all measurement was taken as the facial size.
Cheek Thickness
One arm of caliper was inserted in the lingual embrasure between the lower first and second molar. Other arm was adjusted to touch the skin of the cheek and the caliper held parallel to inter pupillary line of patient. The patient was advised to close the mouth. It was then taken out and the distance between the arms was measured using a scale [11] .
This gave the measurement of the cheek thickness. Preoperative findings were compared with 1st, 3rd and 7th day post-operative findings.
Pain
It was recorded 1st, 3rd and 7th post-operative day using visual analogue scale of 10 cm [12] .
Medications and Surgery
All patients in the study routinely received a prophylactic antibiotic (1 g Amoxicillin) 1 h prior to surgery. A test dose of aprotinin was given to patient with aprotinin 30 min prior to the procedure to rule out drug allergy. In dexamethasone group 8 mg of dexamethasone was administered through intravenous route 30 min before the surgery.
In aprotinin group, to standardize the dose distribution in third molar region we developed a technique by dividing 1 ml aprotinin (i.e. 10,000 kallikrein inactivator units i.e. 0.14 mg/ml) into 0.3, 0.3 and 0.4 ml. After achieving the local anesthesia, 1 ml of aprotinin was infiltrated submucosally in the retromolar (0.4 ml), lingual (0.3 ml) and buccal (0.3 ml) region of impacted mandibular third molar just 5 min before the operation in systematic divided doses. One milliliter disposable syringe with size 25G needles were used for the infiltration. All the patients from the both the group made mouth wash with chlorhexidine 0.2 % before given local anesthesia (inferior alveolar, lingual and long buccal nerve block with 2 % xylocaine with 1:100,000 adrenaline) in the area to be operated. To minimize the operator's variability all surgical extractions were performed by the same surgeon (author G. A.). Third molar removal was performed in a standard manner using Terrence Ward's incision and Gilbe and More collar bone technique using #702 round bur. Wound closure was achieved using 3-0 black braided silk. After the surgery details of operation and duration of surgery (from incision to last suture) were recorded.
Postoperatively antibiotics were not prescribed. All of the patients were prescribed paracetamol 500 mg (1 tablet every 6 h for 2 days) postoperatively.
All patients were discharged after usual post-operative instructions and advised to avoid any medications but those prescribed and not to seek medical help elsewhere for postoperative problems. The patients were reviewed postoperatively on 1st, 2nd and 3rd day respectively and data were recorded.
Results
Post surgical changes compared to base line values and are statistically analyzed by Paired t test/Wilcoxon's signed ranking test and two group comparisons was made by unpaired t test/Mann-Whitney test. The study included total 50 patients (21 males and 29 females) in which 12 males and 13 females were in the group of aprotinin with mean age 26.8 ± 5.9 and range between 20 and 40 years. In dexamethasone group 9 males and 16 females were in mean age of group of 25.3 ± 3.9 with range between 20 and 34 years ( Table 1) .
Duration of Surgery
The duration of surgery were recorded for the both groups. In the aprotinin group the mean duration of the surgery was was found between aprotinin and dexamethasone groups on 3rd post-operative day. Dexamethasone group had significant higher value (mean of all patients, 2.2 ± 1.3 cm) when compared to aprotinin group (mean of all patients, 1.2 ± 1.2 cm) on 3rd post-operative day.
(c) On 7th post-operative day, there was a no statistically significant difference (p value 0.38) between aprotinin and dexamethasone groups (Table 2 ).
In dexamethasone group there was a statistically significant difference found in post-operative swelling on 3rd post-operative day as compared to aprotinin group.
Cheek Girth
Mean comparative efficacies of aprotinin and dexamethasone in reduction of cheek girth in relation to baseline values on 1st, 3rd and 7th post-operative day were as follows.
(a) A statistically significant difference (p value \0.05) was found between aprotinin and dexamethasone groups on 1st post-operative day. Aprotinin group had slightly lower value (mean of all patients, 0.34 ± 0.21 cm) when compared to dexamethasone group (mean of all patients, 0.46 ± 0.14 cm) on 1st post-operative day. (b) A statistically significant difference (p value \0.01) was found between aprotinin and dexamethasone groups on 3rd post-operative day. Dexamethasone group had significantly higher value (mean of all patients, 0.46 ± 0.27 cm) when compared to aprotinin group (mean of all patients, 0.16 ± 0.15 cm) on 3rd post-operative day. (c) On 7th day also, there was a statistically significant difference (p value \0.01) between aprotinin and dexamethasone groups. Aprotinin group had significant lower value (mean of all patients, 0.03 ± 0.08 cm) when compared to dexamethasone group (mean of all patients, 0.16 ± 0.13 cm) ( Table 3 ). There was increase in the base line values of cheek girth or thickness in dexamethasone group as compared to aprotinin found during 1st, 3rd and 7th post-operative day.
Pain
Mean individual and comparative efficacies of aprotinin and dexamethasone in reduction of pain on post-operative day 1, 3 and 7 were as follows.
On the 1st post-operative day in the aprotinin group the mean value of pain score was 3.8 ± 0.7 (p value \0.01) and in dexamethasone group it was 3.8 ± 0.7 (p value \0.01). There was no statistical significant difference between these two groups (p value 0.31) on 1st postoperative day.
On the 3rd post-operative day in the aprotinin group the mean value of pain score was 2.6 ± 1.3 (p value \0.01) and in dexamethasone group it was 3.7 ± 0.7 (p value \0.01). There was a statistically significant difference between these two groups on 3rd post-operative day (p value \0.01).
On the 7th post-operative day in the aprotinin group the mean value of pain score was 2.0 ± 0.6 (p value \0.01) and in dexamethasone group it was 2.3 ± 0.7 (p value \0.01). There was no statistical significance between these two groups (p value 0.10) on 7th day post-operative day (Table 4) .
Discussion
The surgical removal of impacted third molar teeth can result in considerable pain, swelling, and dysfunction. The factors contributing to post-operative pain, and edema, are complex, but many of the contributing factors are related to the inflammatory process. Meticulous surgical techniques will minimize the sequelae of inflammation but will not prevent them.
Post-operative inflammation is characterized by increased vascular permeability, migration of leucocytes into the inflamed area, the release of chemical mediators of inflammation from leucocytes, and interaction of these mediators with other mediators, such as kinin and complement. By pharmacologically controlling the extent of the inflammatory process, post-operative sequelae, such as pain, and swelling, may be reduced in intensity or severity [13] .
In an attempt to overcome these problems, steroids, nonsteroidal anti-inflammatory drugs, anti-histamines, long acting local anaesthetics and antibiotics have been tried with varying degree of success [14, 15] .
Since the introduction of corticosteroids in 1949 for the pharmacologic treatment of rheumatoid arthritis, they have been suggested for the treatment of many inflammatory diseases and for the reduction of inflammatory sequelae of surgical procedures, including the removal of impacted teeth [13] . The anti-inflammatory action of corticosteroid was first discovered by Hench and Co-workers in the treatment of rheumatoid arthritis in 1949 and was awarded Nobel Prize for their discovery. Corticosteroids are well known adjuvant to surgery for suppressing tissue mediators of inflammation, thereby reducing transudation of fluids and lessening edema [7] . Glucocorticoids are a group of steroids that possess antiinflammatory properties. It is a subdivision of adrenocorticoids secreted by the adrenal cortex [16] . The primary glucocorticoid secreted by the zona fasciculata of the adrenal cortex is cortisol (hydrocortisone) [17] . Under normal nonstressful conditions, the body produces approximately 15-30 mg of hydrocortisone per day [18] . Perhaps one of the most important actions of corticosteroids is the suppression or prevention of inflammation by interfering with capillary dilatation, edema formation, fibrin deposition, leucocyte migration, and phagocytosis [19] .
The exact mechanism by which the glucocorticosteroids inhibit inflammation is not fully understood [16] . However, the primary mechanisms thought are effects on movement, suppression and function of leucocytes, accumulation of macrophage at inflammatory site [20] and prevention of prostaglandin synthesis by inhibiting the arachidonic acid cascade [21] . Lipocortin is an endogenous protein produced by steroids. It blocks the activity of phospholipase A2, thus inhibiting the release of arachidonic acid from cell membranes and the synthesis of prostaglandins, leukotrines and thromboxanes [22] .
The most commonly used forms of corticosteroids in dentoalveolar surgery include dexamethasone (oral), dexamethasone sodium phosphate (IV or IM) and dexamethasone acetate (IM), methylprednisolone (oral), methylprednisolone sodium succinate (IV/IM). Many authors recommend a minimum of pre-operative loading dose of 8-12 mg dexamethasone as some studies shown little to no edema reduction with only 4 mg [7] .
Dexamethasone is a white, odorless compound which is slightly soluble in water. It is a synthetic analogue of prednisolone in which a methyl group has been added at the carbon 16 position and a fluorine atom at the carbon 9 position. It has been known that the addition of fluorine atom at the carbon 9 position greatly enhances the anti-inflammatory activity of the resulting compound [3] .
Aprotinin is a bovine derived polypeptide, containing 58 aminoacid residues, and inhibits many of the trypsin like enzymes, including those concerned with the formation of certain mediators of acute inflammation. This property of aprotinin is due to the e-amino side chains of four lysyl residues, which compete with substrates for the active sites of these enzymes. Aprotinin is thus a competitive inhibitor of these enzymes, but is not consumed by them. Kallikrein which forms the potent chemical mediator bradykinin by enzymatically cleaving high molecular weight kininogen in the blood is one such enzyme inhibited by aprotinin. Bradykinin, a non-apeptide, is 10 times more potent as a vasodilator than histamine and causes intense pain when applied to tissue. Since bradykinin is dependent on kallikrein for its activation, aprotinin indirectly inhibits this mediator [23] .
The proteolytic enzyme, plasmin responsible for digesting fibrin and other plasma proteins and activating the potent anaphylotoxin C3a in the complement cascade is also inactivated by aprotinin. The digestion products of fibrin (fibrinopeptides) which have anticoagulant properties, and the ability to increase vascular permeability are therefore also inhibited [8] .
Aprotinin also reduces pain by inhibiting inflammatory mediators which causes pain by stimulating nerve ending and also by reducing the edema or swelling after third molar surgery [8] . Thus aprotinin has a potential antiinflammatory and analgesic property.
In our study aprotinin has proved to be clinically and statistically significant and better over dexamethasone group in controlling post-operative swelling and pain after third molar surgery. The prolonged action of aprotinin (72 h) is quite helpful in reduction of the unwanted sequelae of swelling indicating aprotinin as an effective alternative anti-inflammatory pharmacological agent to dexamethasone in reducing swelling after third molar surgery.
No patient in our study complained of side effects like nausea, vomiting, gastric irritation, urticaria etc. In literature an anaphylactic reaction after primary exposure to an aprotinin test dose (10,000 kallikrein inactivating units) was reported [24, 25] . This 10,000 KIU is the dose that we used as therapeutic dosage of aprotinin in our study. But no such complications were noted in this study.
Finally, use of dexamethasone intravenously when removing impacted third molars has been shown to have objective and subjective benefits [9] . However a real problem with corticosteroids is that administration of large doses can suppress adrenal corticosteroid activity. There is also the problem that the use of glucocorticoids is contraindicated in a number of patients [26] . Potential side effects and the risks with the use of steroids include suppression of immune system, hypertension, hyperglycemia, a sense of euphoria and glaucoma. Absolute contra indications noted are ocular herpes, tuberculosis, primary glaucoma, acute psychosis etc [9] .
Thus when we outweigh the benefits of aprotinin against the risks of dexamethasone several advantages can be listed by the results of our study.
• As aprotinin is given locally, comparatively more invasive parenteral route can be avoided.
• Injection of aprotinin is less traumatic to patients.
• Aprotinin has no contraindication (however hypersensitivity is relative contraindication) [23] .
Thus as many physiological functions are affected by steroids, the side effects are more [27] , local infiltration of aprotinin may provide us a valuable alternative to dexamethasone.
Lastly, it may be possible to utilize the combined properties of both corticosteroid and aprotinin to further reduce swelling and pain. It might be postulated that aprotinin could possibly be beneficial in reducing the incidence of dry socket, owing to its property of preventing the activation of plasmin, a proteolytic enzyme found in developing dry sockets [4] . So further researches are recommended to assess this property along with its ability in wound healing and prevention of blood loss during third molar surgery.
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